Document is current
Any future updates will be listed below
-
Authors
Fauchier, Gregoire https://orcid.org/0000-0003-2543-3980
Bisson, Arnaud https://orcid.org/0000-0002-3449-1800
Bodin, Alexandre https://orcid.org/0000-0002-6544-3916
Herbert, Julien https://orcid.org/0000-0003-0373-9591
Angoulvant, Denis https://orcid.org/0000-0003-0788-8092
Ducluzeau, Pierre Henri https://orcid.org/0000-0001-6109-0386
Lip, Gregory Y. H. https://orcid.org/0000-0002-7566-1626
Fauchier, Laurent https://orcid.org/0000-0002-9267-1658
- License Information
-
More Information
Article History
Received: 19 May 2021
Accepted: 16 July 2021
First Online: 25 August 2021
Conflict of interest disclosures
: None directly related to the matter of this article. DA has received fees for lectures or consulting from Amgen, Sanofi, Novartis, AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, MSD, Pfizer and Servier. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim and Daiichi-Sankyo. No fees are received personally. LF reports consultant or speaker activities for AstraZeneca, Bayer, BMS/Pfizer, Boehringer Ingelheim, Medtronic, Novartis and XO. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Free to read: This content has been made available to all.
